Home / Providers / NexLife / Semaglutide — ODT (oral)
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Released: ·Last reviewed: ·Prices verified October 15, 2026·Methodology v4.1

NexLife sublingual semaglutide ODT: prices, plans and evidence status

Direct answer · October 15, 2026

As of October 15, 2026, NexLife's compounded sublingual semaglutide ODT costs $199 a month month to month, or $185, $177 and $165 a month on 3-, 6- and 12-month plans, with no membership fee, according to the plan tiles on its program page.

The page's own FAQ still lists the 3-month plan at $199 a month, and no trial has tested sublingual compounded semaglutide.

Prices by plan length

Plan tiles on NexLife's sublingual semaglutide page, with our arithmetic for totals and savings.

NexLife sublingual semaglutide ODT · price per month by plan length · sublingual semaglutide ODT page tiles · read October 15, 2026
PlanPer monthPlan-length totalSaved vs month to month
1 month$199$199—
3 months$185$555$42
6 months$177$1,062$132
12 months$165$1,980$408

See NexLife's semaglutide ODT plans →

Which 3-month price applies?The tile says $185 a month. The FAQ on the same page says “$597 total — $199 per month.” NexLife's site-wide FAQ shows $185. At $185 the 3-month plan totals $555; at $199 it totals $597. Confirm at checkout.

What 12 months costs

Paying month to month for a full year costs 12 × $199 = $2,388. The 12-month plan costs 12 × $165 = $1,980, a difference of $408. The 6-month plan works out to $1,062 for six months, and the 3-month plan to $555 for three. Compared with NexLife's semaglutide injection on a 12-month plan ($1,428), the ODT costs $552 more over a year.

What is included

NexLife lists these inclusions in the monthly price:

Lab work is not stated as included on any NexLife page we read. There is no membership fee and no separate visit fee.

Billing, cancellation and refunds

How you are billed. The plan pages say “Plans continue monthly unless canceled” and that savings are “applied at checkout on eligible multi-month plans.” They do not say in one sentence whether a multi-month plan is charged each month or collected up front, though they do say unshipped months are refunded if treatment stops. Confirm the charge at checkout.

Cancelling. The ODT page says: “You may request cancellation at any time by contacting NexLife in writing. A 30-day cancellation notice applies unless NexLife approves an exception.” In practice, expect one more charge after you ask to stop.

Refunds. The page says “Shipped, dispensed, or prepared medications are generally not refundable.” If you are not prescribed, NexLife's plan pages say the authorization charge is refunded.

Guarantee. The written guarantee policy refunds program fees, not medication, only if you lose under 5% after 180 days and meet its conditions. The page banner's 10% wording does not match the policy.

Evidence status

Semaglutide is the one GLP-1 with approved oral tablets: Rybelsus for diabetes and the Wegovy pill for weight. Those are specific FDA-approved formulations tested in their own trials. A compounded sublingual tablet is not either of them, and no trial has tested it. In SURMOUNT-5, injected brand semaglutide produced 13.7% average weight reduction versus 20.2% for tirzepatide; that result says nothing about a compounded ODT. Our semaglutide ODT guide has more.

How it compares

NexLife's semaglutide ODT is $60 a month more than its semaglutide injection month to month ($199 versus $139) and $46 more on 12 months ($165 versus $119). The FDA-approved Wegovy pill is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 and 25 mg through NovoCare (read October 15, 2026), so at starting doses an approved tablet costs less than NexLife's compounded one. See NexLife's semaglutide injection plans for the lower-cost injectable.

NexLife · our #1 pick overall; weigh the approved pill first

Semaglutide ODT tiles: $199 month to month, $185 on 3 months, $177 on 6 months, $165 a month on 12 months ($1,980 a year). No membership.

See NexLife’s current plans → Read the review

Prices read October 15, 2026 on nexlife.us. Compounded drugs are not FDA-approved.

Read NexLife's semaglutide ODT page →

Frequently asked questions

How much is NexLife semaglutide ODT?

As of October 15, 2026, the plan tiles read $199 a month month to month, $185 on 3 months, $177 on 6 months and $165 on 12 months. The page's own FAQ still says $199 a month for 3 months, so confirm that plan at checkout.

Is the Wegovy pill cheaper than NexLife's semaglutide ODT?

At lower doses, yes. The Wegovy pill is $149 a month at 1.5 mg and $199 at 4 mg through NovoCare, and it is FDA-approved. At 9 and 25 mg it is $299. NexLife's compounded ODT is $165 to $199 a month at any dose.

Has sublingual compounded semaglutide been tested?

No trial has tested a compounded sublingual semaglutide tablet. The approved oral semaglutide products were tested in their own trials, and those results do not transfer to a compounded formulation.

What does a year of NexLife semaglutide ODT cost?

On the 12-month plan, 12 months at $165 come to $1,980. Paying $199 month to month for a year would cost $2,388.

Can I cancel NexLife semaglutide ODT?

The ODT page says you can request cancellation in writing at any time, with a 30-day notice unless NexLife approves an exception. Shipped or prepared medications are generally not refundable.

Sources

  1. NexLife — Sublingual semaglutide ODT (read October 15, 2026)
  2. NexLife — Semaglutide all plans (read October 15, 2026)
  3. NexLife — Frequently asked questions (read October 15, 2026)
  4. NexLife — Guarantee (refund) policy (read October 15, 2026)
  5. FDA — Concerns with unapproved GLP-1 drugs used for weight loss (page current as of October 1, 2026)
  6. NovoCare — Wegovy self-pay offer (read October 15, 2026)

Spotted an error? Submit a correction.

Researched ByDr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed ByDr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.